Awards provide real world evidence that UK pharma remains at its innovative best London, 21st September, 2016. The first new treatment for heart failure in 15 years and Europe’s first approved stem cell therapy have scooped top prizes at the 2016 UK Prix Galien Awards. Novartis’ Entresto and Chiesi’s Holoclar won two of the three …
